By RT-PCR, mass spectrometry and flow cytometric analysis, hADs (1–3) have been shown to be expressed by cell lines deriving from renal cell carcinomas and the expression of a specific hAD precursor peptide has been shown to be upregulated in human leukemic cells. The gene discussed is HADH; the disease is hereditary clear cell renal cell carcinoma.